PRINCETON, N.J., June 22 /PRNewswire-FirstCall/ -- Novo Nordisk today
announced the arrival of the Changing Diabetes Bus world tour in the United
States. The Bus tour is making its U.S. debut in Chicago at Navy Pier's
South Gateway Park as part of a five-continent, 18-month journey around the
world to change diabetes. Long-standing diabetes advocate Chicago Bears
Head Coach Lovie Smith will kick off opening day ceremonies on June 22 at
Diabetes affects nearly 21 million people nationwide and is a serious
public health concern. About 1.5 million new cases of diabetes are
diagnosed each year in the United States.
"Education is the key if we are to ensure that future generations do
not suffer needlessly from type 2 diabetes, which is a preventable
disease," said Chicago Bears Head Coach Lovie Smith. "Right now, there are
more than 400,000 Chicagoland residents living with diabetes 1, enough to
fill Soldier Field 6 times over. I am teaming up with Novo Nordisk to call
on Americans to change diabetes for good, by learning about the importance
of good lifestyle habits, like proper nutrition and exercise in preventing
the onset of type 2 diabetes."
The centerpiece of this tour is the Changing Diabetes Bus, a 59-foot
mobile showroom filled with interactive, multimedia exhibits where visitors
can learn about diabetes and why controlling it is critical - for
themselves and their loved ones. Visitors can also share their opinions
about what they would change in the area of diabetes and view testimonials
from people across the globe who have visited the Bus.
The Bus is at the heart of a custom-built Changing Diabetes Village, a
park encompassing nearly 25,000 square feet and offering complementary
health screenings, information about diabetes from the American Diabetes
Association, free healthy refreshments, fitness instruction, stretching
tips by former ballerina and diabetes patient Zippora Karzand an area
designated specifically for children's activities.
Admission to the Changing Diabetes Bus and Village is free and open to
the public from June 22-25, 11:00 AM - 5:00 PM.
"Our goal is to reach as many people as possible with information about
diabetes and diabetes care," remarked Dr. Alan C. Moses, Chief Medical
Officer for Novo Nordisk. "We want visitors to join Novo Nordisk in
changing diabetes, and learn what they can do to help change the future of
diabetes today. Novo Nordisk is a longstanding leader in diabetes care, and
we will continue to be a catalyst for change - for example, our recent work
in support of the United Nations' landmark Resolution on diabetes."
Unite for Diabetes
In June of 2006, the International Diabetes Federation (IDF) launched a
worldwide "Unite for Diabetes" campaign. This campaign called on the United
Nations (UN) to add diabetes on the global health agenda. As a result, the
UN passed a Resolution on diabetes recognizing the disease as a serious
worldwide health threat and calling on member states to develop national
policies for the prevention, treatment and care of diabetes in line with
sustainable development of their healthcare systems. The UN passed the
Resolution in December 2006, and it sanctioned November 14 as World
A strong symbol for the "Unite for Diabetes" campaign has been created
enabling everyone to engage in the vision of the UN Resolution: a blue
circle, which signifies unity.
Novo Nordisk is proud to support "Unite for Diabetes. "Focusing on the
needs of children and youth, their families and social networks, the Novo
Nordisk Changing Diabetes Bus world tour has a mandate to raise awareness
of diabetes and its social, humanitarian and economic consequences among 1
Since its launch, nearly 61,177 people have visited the Changing
Novo Nordisk is a healthcare company with an 84-year history of
innovation and achievement in diabetes care. The company has the broadest
diabetes product portfolio in the industry, including the most advanced
products within the area of insulin delivery systems. In addition to
diabetes care, Novo Nordisk has a leading position within areas such as
hemostasis management, growth hormone therapy, and hormone therapy for
women. Novo Nordisk's business is driven by the Triple Bottom Line: a
commitment to economic success, environmental soundness, and social
responsibility to employees and customers. With headquarters in Denmark,
Novo Nordisk employs more than 23,600 employees in 79 countries, and
markets its products in 179 countries. Novo Nordisk's B shares are listed
on the stock exchanges in Copenhagen and London. Its ADRs are listed on the
New York Stock Exchange under the symbol 'NVO'. For global information,
visit novonordisk.com; for United States information, visit
For more information about the Changing Diabetes Bus, please visit:
Changing Diabetes is a service mark of Novo Nordisk A/S.
SOURCE Novo Nordisk Inc.